MENU
NEO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

NeoGenomics (NEO) Earnings Date & Reports

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology... Show more

A.I. Advisor
published Earnings

NEO is expected to report earnings to fall 30.67% to 2 cents per share on November 11

NeoGenomics NEO Stock Earnings Reports
Q3'25
Est.
$0.02
Q2'25
Beat
by $0.01
Q1'25
Beat
by $0.01
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.04
The last earnings report on July 29 showed earnings per share of 2 cents, beating the estimate of 1 cents. With 835.52K shares outstanding, the current market capitalization sits at 749.24M.
View a ticker or compare two or three
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NEO showed earnings on July 29, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a provider of genetic and molecular testing services

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Or Nursing Services
Address
9490 NeoGenomics Way
Phone
+1 239 768-0600
Employees
2100
Web
https://www.neogenomics.com